UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Meta-analysis of individual patient data from randomized trials of chemotherapy plus cetuximab as first-line treatment for advanced non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2014-02, Vol.83 (2), p.211-218

2014

Link zum Volltext

Verfügbarkeit prüfen

Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC

Lung cancer (Amsterdam, Netherlands), 2019-09, Vol.135, p.217-227

2019

Link zum Volltext

Verfügbarkeit prüfen

The role of prostacyclin synthase and thromboxane synthase signaling in the development and progression of cancer

Biochimica et biophysica acta, 2010-04, Vol.1805 (2), p.153-166

2010

Link zum Volltext

Verfügbarkeit prüfen

COX-derived prostanoid pathways in gastrointestinal cancer development and progression: Novel targets for prevention and intervention

Biochimica et biophysica acta, 2012-01, Vol.1825 (1), p.49-63

2012

Link zum Volltext

Verfügbarkeit prüfen

Tyrosine kinase inhibitors as modulators of trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity in breast cancer cell lines

Cellular immunology, 2017-09, Vol.319, p.35-42

2017

Link zum Volltext

Verfügbarkeit prüfen

Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2019-06, Vol.132, p.126-131

2019

Link zum Volltext

Verfügbarkeit prüfen

Thromboxane synthase expression and correlation with VEGF and angiogenesis in non-small cell lung cancer

Biochimica et biophysica acta, 2014-05, Vol.1842 (5), p.747-755

2014

Link zum Volltext

Verfügbarkeit prüfen

Targeting the fibroblast growth factor receptor family in cancer

Cancer treatment reviews, 2016-05, Vol.46, p.51-62

2016

Link zum Volltext

Verfügbarkeit prüfen

Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer

Lung cancer (Amsterdam, Netherlands), 2012-04, Vol.76 (1), p.19-25

2012

Link zum Volltext

Verfügbarkeit prüfen

Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables

Lung cancer (Amsterdam, Netherlands), 2002-09, Vol.37 (3), p.235-240

2002

Link zum Volltext

Verfügbarkeit prüfen

How does the Timing of Chemotherapy Affect Outcome Following Radical Surgery for Malignant Pleural Mesothelioma?

Lung cancer (Amsterdam, Netherlands), 2016-10, Vol.100, p.5-13

2016

Link zum Volltext

Verfügbarkeit prüfen

IL-23 is pro-proliferative, epigenetically regulated and modulated by chemotherapy in non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2013-01, Vol.79 (1), p.83-90

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinico-pathological and biological prognostic factors in pleural malignant mesothelioma

Lung cancer (Amsterdam, Netherlands), 2004-08, Vol.45, p.S45-S48

2004

Link zum Volltext

Verfügbarkeit prüfen

hSSB1 phosphorylation is dynamically regulated by DNA-PK and PPP-family protein phosphatases

DNA repair, 2017-06, Vol.54, p.30-39

2017

Link zum Volltext

Verfügbarkeit prüfen

Vascular endothelial growth factor platelet counts, and prognosis in renal cancer

The Lancet (British edition), 1999-05, Vol.353 (9163), p.1494-1495

1999

Link zum Volltext

Verfügbarkeit prüfen

Long-term comparative efficacy and safety of nivolumab plus ipilimumab relative to other first-line therapies for advanced non-small-cell lung cancer: A systematic literature review and network meta-analysis

Lung cancer (Amsterdam, Netherlands), 2023-03, Vol.177, p.11-20

2023

Link zum Volltext

Verfügbarkeit prüfen

Epidermal growth factor receptors and cyclooxygenase-2 in the pathogenesis of non-small cell lung cancer: potential targets for chemoprevention and systemic therapy

Lung Cancer, 2003, Vol.39 (1), p.1-13

2003

Link zum Volltext

Verfügbarkeit prüfen

Bcl-2 is an independent prognostic factor and adds to a biological model for predicting outcome in operable non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2001-12, Vol.34 (3), p.417-426

2001

Link zum Volltext

Verfügbarkeit prüfen

Evolution, immune response, and cancer

The Lancet (British edition), 2000-09, Vol.356 (9234), p.1033-1034

2000

Link zum Volltext

Verfügbarkeit prüfen

O-138 Tumour necrosis factor-alpha cell signalling events in human bronchoepithelial cells

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S43-S43

2003

Link zum Volltext

Verfügbarkeit prüfen

Infection and cancer

The Lancet (British edition), 2001-07, Vol.358 (9276), p.156-156

2001

Link zum Volltext

Verfügbarkeit prüfen

SP-325 elective cyclooxygenase (COX)-2 inhibitors in combination with cytokines induce growth arrest in non-small cell lung cancer cell lines at clinically relevant doses

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S174-S174

2003

Link zum Volltext

Verfügbarkeit prüfen

P-489 Hypoxia inducible factor-1 alpha in non-small cell lung cancer: Relation to other biological factors and prognosis

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S214-S214

2003

Link zum Volltext

Verfügbarkeit prüfen

P-479 The expression and prognostic significance of Akt and phosphorylated Akt (pAkt) in non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S212-S212

2003

Link zum Volltext

Verfügbarkeit prüfen

O-78 Microarray analysis of mesothelial cells treated with crocidolite, erionite, IL-1beta and TNF-alpha

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S25-S26

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieEuropean Journal Of Cancer

ThemaLung Cancer

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(20)
Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Oncology
(14)
Respiratory System
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(9)
Non-Small Cell Lung Cancer
(7)
Pneumology
(7)
Tumors Of The Respiratory System And Mediastinum
(7)
Female
(6)
Male
(6)
Adult
(5)
Hematology, Oncology And Palliative Medicine
(5)
Lung Neoplasms - Drug Therapy
(5)
Middle Aged
(5)
Neoplasm Staging
(5)
Aged
(4)
Angiogenesis
(4)
Animals
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Meta-analysis of individual patient data from randomized trials of chemotherapy plus cetuximab as first-line treatment for advanced non-small cell lung cancer

Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC

The role of prostacyclin synthase and thromboxane synthase signaling in the development and progression of cancer

COX-derived prostanoid pathways in gastrointestinal cancer development and progression: Novel targets for prevention and intervention

Tyrosine kinase inhibitors as modulators of trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity in breast cancer cell lines

Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer

Thromboxane synthase expression and correlation with VEGF and angiogenesis in non-small cell lung cancer

Targeting the fibroblast growth factor receptor family in cancer

Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer

Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables

How does the Timing of Chemotherapy Affect Outcome Following Radical Surgery for Malignant Pleural Mesothelioma?

IL-23 is pro-proliferative, epigenetically regulated and modulated by chemotherapy in non-small cell lung cancer

Clinico-pathological and biological prognostic factors in pleural malignant mesothelioma

hSSB1 phosphorylation is dynamically regulated by DNA-PK and PPP-family protein phosphatases

Vascular endothelial growth factor platelet counts, and prognosis in renal cancer

Long-term comparative efficacy and safety of nivolumab plus ipilimumab relative to other first-line therapies for advanced non-small-cell lung cancer: A systematic literature review and network meta-analysis

Epidermal growth factor receptors and cyclooxygenase-2 in the pathogenesis of non-small cell lung cancer: potential targets for chemoprevention and systemic therapy

Bcl-2 is an independent prognostic factor and adds to a biological model for predicting outcome in operable non-small cell lung cancer

Evolution, immune response, and cancer

O-138 Tumour necrosis factor-alpha cell signalling events in human bronchoepithelial cells

Infection and cancer

SP-325 elective cyclooxygenase (COX)-2 inhibitors in combination with cytokines induce growth arrest in non-small cell lung cancer cell lines at clinically relevant doses

P-489 Hypoxia inducible factor-1 alpha in non-small cell lung cancer: Relation to other biological factors and prognosis

P-479 The expression and prognostic significance of Akt and phosphorylated Akt (pAkt) in non-small cell lung cancer

O-78 Microarray analysis of mesothelial cells treated with crocidolite, erionite, IL-1beta and TNF-alpha

Aktive Filter

Suchergebnisse filtern